Ribociclib Free Base, also known as LEE011, is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. CDK4/6 inhibitor LEE011 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation.
Reddy, Peddireddy Subba; Kumar, Kottur Mohan; Oruganti, Srinivas; Kandagatla, Bhaskar; Das Gupta, Shirshendu. Process for preparation of Ribociclib and its acid addition salts. WO 2018051280. (PCT Int. Appl. (2018))
Xu, Xuenong. Process for preparation of Ribociclib intermediate. WO 2016192522. (PCT Int. Appl. (2016))
Calienni, John Vincent; Chen, Guang-Pei; Gong, Baoqing; Kapa, Prasad Koteswara; Saxena, Vishal. Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof. US 20160039832. (U.S. Pat. Appl. Publ. (2016))
Calienni, John Vincent; Chen, Guang-Pei; Gong, Baoqing; Kapa, Prasad Koteswara; Saxena, Vishal. Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof. US 20120115878 (U.S. Pat. Appl. Publ. (2012))
Borland, Maria; Brain, Christopher Thomas; Doshi, Shivang; Kim, Sunkyu; Ma, Jianguo; Murtie, Josh; Zhang, Hong. Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor and an Mtor inhibitor for treating cancer. WO 2011130232. (PCT Int. Appl. (2011))
Besong, Gilbert; Brain, Christopher Thomas; Brooks, Clinton A.; Congreve, Miles Stuart; Dagostin, Claudio; He, Guo; Hou, Ying; Howard, Steven; Li, Yue; Lu, Yipin; et al. Preparation of pyrrolopyrimidine compounds as CDK inhibitors. WO 2010020675. (PCT Int. Appl. (2010))
Chen, Linghao. Process for synthesis of Ribociclib. Assignee Qingdao Chenda Biotechnology Co., Ltd., Peop. Rep. China. CN 106928236 A (2017).
Sokhi, Sarbjot Singh; Singh, Govind; Lahiri, Saswata; Pandey, Maneesh Kumar; Tiwari, Raj Narayan; Shukla, Sonu; Musmade, Sachin; Dua, Heena; Cabri, Walter. An improved process for the preparation of Ribociclib and its salts. Assignee Fresenius Kabi Oncology Ltd., India. WO 2019082143 A1 (2019).
Wu, Ke; He, Wei; Peng, Lei; Wang, Longlin; Jiang, Guangding; Yang, Fan. Method for preparing Ribociclib. Assignee Chongqing Sansheng Industrial Co., Ltd., Peop. Rep. China. CN 109400612 A. (2019).
Song, Lei. Method for rapidly synthesizing Ribociclib. Assignee Southwest University for Nationalities, Peop. Rep. China. CN 108623599 A. (2018).
